Eyenovia reports fourth quarter and full-year 2023 financial results and provides business update

Announced fda approval of clobetasol propionate ophthalmic suspension 0.05% for post-operative pain and inflammation following ocular surgery
EYEN Ratings Summary
EYEN Quant Ranking